menu
    • menu

    Company profile for Pasithea Therapeutics

    NEW Drugs in Dev: 6
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pasithea Therapeutics a biopharmaceutical company dedicated to developing new therapies for the treatment of central nervous system (CNS) diseases. The flagship company program is focused on discovering new and effective treatments for mental health problems. Our vision is to transform the treatment of people who suffer from psychiatric and neurological disorders. Pasithea Therapeutics is a biotech company at the forefront of...
    Pasithea Therapeutics a biopharmaceutical company dedicated to developing new therapies for the treatment of central nervous system (CNS) diseases. The flagship company program is focused on discovering new and effective treatments for mental health problems. Our vision is to transform the treatment of people who suffer from psychiatric and neurological disorders. Pasithea Therapeutics is a biotech company at the forefront of research into solving one of the world’s biggest problems: mental health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pasithea TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1111 Lincoln Road Suite 500 Miami Beach FL 33139
    Telephone
    Telephone
    +1 786-977-3380
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pasithea.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pasitheacorp/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BD&L Summit

    BD&L Summit

    Not Confirmed

    envelop Contact Supplier

    BD&L Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pasithea Therapeutics Announces Grant of RPDD by FDA to PAS-004
    Pasithea Therapeutics Announces Grant of RPDD by FDA to PAS-004

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276869/0/en/pasithea-therapeutics-announces-grant-of-rare-pediatric-disease-designation-rpdd-by-fda-to-pas-004-for-treatment-of-neurofibromatosis-type-1-nf1.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    Pasithea Therapeutics to Present at Oppenheimer HLS Conference
    Pasithea Therapeutics to Present at Oppenheimer HLS Conference

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239091/0/en/Pasithea-Therapeutics-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Pasithea Therapeutics Reveals PAS-004 Clinical Program Updates
    Pasithea Therapeutics Reveals PAS-004 Clinical Program Updates

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217645/0/en/Pasithea-Therapeutics-Provides-Outlook-on-PAS-004-Clinical-Programs-and-Data-Release-Timelines.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Pasithea Therapeutics Closes $60M Public Stock Offering
    Pasithea Therapeutics Closes $60M Public Stock Offering

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197740/0/en/Pasithea-Therapeutics-Announces-Closing-of-60-Million-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share
    Pasithea Therapeutics Prices $60M Public Stock Offering
    Pasithea Therapeutics Prices $60M Public Stock Offering

    28 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/28/3196323/0/en/Pasithea-Therapeutics-Announces-Pricing-of-60-Million-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    28 Nov 2025
    Share Share
    Pasithea Therapeutics Receives $1M by ALS Association Grant
    Pasithea Therapeutics Receives $1M by ALS Association Grant

    25 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/25/3194202/0/en/Pasithea-Therapeutics-Announces-1-Million-Award-by-ALS-Association-to-Study-the-Efficacy-Safety-and-Tolerability-of-PAS-004-for-Treatment-of-ALS.html

    GLOBENEWSWIRE
    25 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search